News from Zyme and the companies we work with.
ProImmune Introduces Mastering Immunity 2026 – Shanghai Symposium to Address Key Immunogenicity Challenges
Symposium brings together global leaders in immunogenicity to connect with China’s rapidly evolving pharmaceutical development landscape Speakers include thought leaders in biotherapeutics, complex peptide drug developers, and regulatory authorities In-person [...]
SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT’s firefly platform
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud Validated methods support Twist FlexPrep™ UHT and Enzymatic Fragmentation Kit 2.0, enabling higher throughput [...]
Axol Bioscience raises $2.8M to advance US expansion and product development
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK, 13th January 2026: [...]
Optibrium Appoints Dr Nathan Brown as Director of Science
Newly created role underscores commitment to customer-driven research and scientific excellence CAMBRIDGE, UK, 13 January 2026 – Optibrium, a leading developer of software and AI solutions for molecular design, today [...]
Nuclera extends Series C funding to $87M to advance antibody engineering
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh The funding will accelerate development of eProtein Discovery for full-format [...]
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme Cambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company [...]
iXCells Biotechnologies appoints Steve Smith as CEO
Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services San Diego, CA, 12 January, 2026: iXCells Biotechnologies (“iXCells”), [...]
FairJourney Bio launches cryo-EM services with advanced laboratories in San Diego, USA
Expanded offering provides high-resolution structural insights to support antibody discovery and biologic design PORTO, Portugal, and SAN DIEGO, USA, 12 January 2026 – FairJourney Bio (FJBio), a leading global provider [...]
Qureight appoints Rebecca Simmons as Chief Operating Officer
Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operations Cambridge, UK, 12 January 2026 – Qureight, [...]
Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases Cambridge, UK, 09 January 2026: Enhanced Genomics (‘Enhanced’ or [...]
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at [...]
Nuclera eProtein Discovery System installed at leading Universities in Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia System strengthens Taiwan’s capabilities in protein drug discovery research Cambridge, [...]
